Infectious Diseases Archive — Page 9 of 13

Gloved hands hold a blood sample tube labeled “Monkeypox,” with the positive box checked.
August 16, 2022

Q&A: Reassurance for parents on mpox risk, spread and symptoms

A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children.

Head-and-shoulders portrait of James Antoon, MD, PhD, MPH, wearing a navy suit, white shirt, and blue patterned tie against a dark gray background.
August 4, 2022

Study tracks limited use of influenza antiviral therapy

A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment.

A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
July 21, 2022

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development

Colorized scanning electron micrograph showing clusters of purple, round MRSA bacteria against a black background.
June 2, 2022

Bacterial battle in 3D

Using imaging mass spectrometry and microscopy, Vanderbilt researchers visualized how staph bacteria modifies lipids in its membrane to evade immune system-mediated killing.

Two researchers stand smiling in a laboratory, with shelves of bottles, equipment, and a teal container behind them.
May 5, 2022

VUMC team discovers how bacterial pathogen survives without water

Vanderbilt researchers are studying a bacterial pathogen that can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections.

Eric Skaar, PhD, MPH, Hualiang Pi, PhD, and colleagues are studying a regulatory factor in the bacterium that causes the disease anthrax.
April 7, 2022

Study advances understanding of bacterial bioterrorism agent

Vanderbilt researchers have identified a critical regulatory factor in the bacterium that causes the disease anthrax and has been used as a biological weapon.